Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency

Dawn E W Livingstone, Sarah L Grassick, Gillian L Currie, Brian R Walker, Ruth Andrew, Dawn E W Livingstone, Sarah L Grassick, Gillian L Currie, Brian R Walker, Ruth Andrew

Abstract

In obese humans, metabolism of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) and A-ring reduction (by 5 alpha- and 5 beta-reductases) is dysregulated in a tissue specific manner. These changes have been recapitulated in leptin resistant obese Zucker rats but were not observed in high-fat fed Wistar rats. Recent data from mouse models suggest that such discrepancies may reflect differences in leptin signalling. We therefore compared glucocorticoid metabolism in murine models of leptin deficiency and resistance. Male ob/ob and db/db mice and their respective littermate controls (n=10-12/group) were studied at the age of 12 weeks. Enzyme activities and mRNA expression were quantified in snap-frozen tissues. The patterns of altered pathways of steroid metabolism in obesity were similar in ob/ob and db/db mice. In liver, 5 beta-reductase activity and mRNA were increased and 11 beta-HSD1 decreased in obese mice, whereas 5 alpha-reductase 1 (5 alpha R1) mRNA was not altered. In visceral adipose depots, 5 beta-reductase was not expressed, 11 beta-HSD1 activity was increased and 5 alpha R1 mRNA was not altered in obesity. By contrast, in subcutaneous adipose tissue 11 beta-HSD1 and 5 alpha R1 mRNA were decreased. Systematic differences were not found between ob/ob and db/db murine models of obesity, suggesting that variations in leptin signalling through the short splice variant of the Ob receptor do not contribute to dysregulation of glucocorticoid metabolism.

Figures

Figure 1
Figure 1
Glucocorticoid metabolic pathways. A is 11-dehydrocorticosterone; B is corticosterone and HSD is hydroxysteroid dehydrogenase.
Figure 2
Figure 2
Hepatic glucocorticoid metabolism. 11β-HSD1 activity measured as velocity of formation of product following incubation of [3H]4-corticosterone with hepatic homogenate from (A) Db/? control (open) or db/db mice (light striped); (B) Ob/? control (black) or ob/ob mice (dark striped). 5β-Reductase activity measured as velocity of formation of product following incubation of [3H]4-corticosterone with hepatic cytosol from (C) Db/? control or db/db mice; (D) Ob/? control or ob/ob mice. Abundance of mRNAs for hepatic enzymes measured by real-time PCR (corrected for 18S as a housekeeping gene and presented as a percentage of respective control group) in (E) Db/? control or db/db mice; (F) Ob/? control mice or ob/ob mice. Data are mean±s.e.m.; n=10–12/group; *P<0·05; **P<0·01.
Figure 3
Figure 3
Glucocorticoid metabolism in adipose tissues. 11β-HSD1 activity measured as velocity of formation of product following incubation of [3H]4-corticosterone with homogenates of adipose tissues from (A) Db/? control (open) or db/db mice (light striped); (B) Ob/? control (black) or ob/ob mice (dark striped). Abundance of mRNA for 11β-HSD1 in adipose tissue depots measured by real-time PCR (corrected for cyclophilin A as a housekeeping gene and presented as a percentage of respective control group) in (C) Db/? control or db/db mice; (D) Ob/? control or ob/ob mice. Abundance of mRNAs for 5α-R1 in adipose beds measured by real-time PCR (corrected for cyclophilin A as a housekeeping gene and presented as a percentage of respective control group) in (E) Db/? control or db/db mice; (F) Ob/? control or ob/ob mice. Subcut is s.c. adipose, Epi is epididymal, R/P is retro-peritoneal and Mes is mesenteric. Data are mean±s.e.m.; n=6–12/group; *P<0·05; **P<0·01.

References

    1. Alberts P, Engblom L, Edling N, Forsgren M, Klingstrom G, Larsson C, Rönquist-Nii Y, Öhman B, Abrahmsén L. Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia. 2002;45:1528–1532.
    1. Andrew R, Walker BR. Glucocorticoid metabolism in health and disease. Recent Research Developments in Endocrinology. 2002;3:425–449.
    1. Andrew R, Phillips DIW, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. Journal of Clinical Endocrinology and Metabolism. 1998;83:1806–1809.
    1. Barat P, Livingstone DEW, Elferink C, MacDonnell R, Walker BR, Andrew R. Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats. Endocrinology. 2007;148:4836–4843.
    1. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect ‘Cushing's disease of the omentum’? Lancet. 1997;349:1210–1213.
    1. Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA, Stewart PM. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology. 2005;34:675–684.
    1. Chua SC, Chung WK, Wu-Peng XS, Zhang Y, Liu S-M, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 1996;271:994–996.
    1. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science. 1996;274:1185–1188.
    1. Drake AJ, Livingstone DEW, Morton NM, Andrew R, Seckl JR, Walker BR. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high fat feeding in rats. Endocrinology. 2005;146:913–919.
    1. Eicheler W, Seitz J, Steinhoff M, Forssmann WG, Adermann K, Aumuller G. Distribution of rat hepatic steroid 5alpha-reductase 1 as shown by immunohistochemistry. Experimental and Clinical Endocrinology and Diabetes. 1995;103:105–112.
    1. Einarsson K, Gustafsson J-A. Neonatal imprinting of liver microsomal hydroxylation and reduction of steroids. Journal of Biological Chemistry. 1973;248:4987–4997.
    1. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E, Connell JMC. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. American Journal of Physiology. Endocrinology and Metabolism. 1999;33:1364–1368.
    1. Gilmour JS, Coutinho AE, Cailhier J.-F, Man TY, Clay M, Thomas G, Harris HG, Mullins JJ, Seckl JR, Savill JS, et al. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes. Journal of Immunology. 2006;176:7605–7611.
    1. Goedecke JH, Wake DJ, Levitt NS, Lambert EV, Collins MR, Morton NM, Andrew R, Walker BR, Seckl JR. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome. Clinical Endocrinology. 2006;65:81–87.
    1. Gustafsson J-A, Stenberg A. Irreversible androgenic programming at birth of microsomal and soluble rat liver steroid metabolism by neonatal testosterone. Journal of Biological Chemistry. 1974;249:711–718.
    1. Hermanowski-Vosatka A, Gerhold D, Mundt SS, Loving VA, Lu M, Chen Y, Elbrecht A, Wu M, Doebber T, Kelly L, et al. PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver. Biochemical and Biophysical Research Communications. 2000;279:330–336.
    1. Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS, et al. 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. Journal of Experimental Medicine. 2005;202:517–527.
    1. Hoggard N, Mercer JG, Rayner DV, Moar K, Trayhurn P, Williams LM. Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochemical and Biophysical Research Communications. 1997;232:383–387.
    1. Holmes MC, French KL, Seckl JR. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Molecular Brain Research. 1995;28:186–192.
    1. Horton R, Pasupuletti V, Antonipillai I. Androgen induction of steroid 5α-reductase may be mediated via insulin-like growth factor-1. Endocrinology. 1993;133:447–451.
    1. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR. 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology. 1995;136:4754–4761.
    1. Jang C, Obeyesekere VR, Dilley RJ, Alford FP, Inder WJ. 11β-Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle. Clinical Endocrinology. 2006;65:800–805.
    1. Jansson JO, Ekberg S, Isaksson O. Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone. Endocrinology. 1985;117:1881–1889.
    1. Lee G-H, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996;379:632–635.
    1. Lindsay RS, Tataranni A, Permana P, Livingstone DEW, Wake DJ, Walker BR. Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and mRNA levels are associated with adiposity and insulinaemia in Pima Indians and Caucasians. Journal of Clinical Endocrinology and Metabolism. 2003;88:2738–2744.
    1. Liu Y, Nakagawa Y, Wang Y, Li R, Li X, Ohzeki T, Friedman TC. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycaemia in leptin deficient ob/ob mice. Diabetes. 2003;52:1409–1416.
    1. Liu Y, Nakagawa Y, Wang Y, Sakurai R, Tripathi PV, Lutfy K, Friedman TC. Increased glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes. 2005;54:32–40.
    1. Livingstone DEW, Jones GC, Smith K, Andrew R, Kenyon CJ, Walker BR. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology. 2000;141:560–563.
    1. Livingstone DEW, McInnes KJ, Walker BR, Andrew R. Increased A-ring reduction of glucocorticoids in obese rats: attenuation by insulin sensitisation. Obesity Research. 2005;13:1523–1526.
    1. Low SC, Moisan M-P, Edwards CRW, Seckl JR. Glucocorticoids and chronic stress up-regulate 11b-hydroxysteroid dehydrogenase activity and gene expression in the hippocampus. Journal of Neuroendocrinology. 1994;6:285–290.
    1. Mahendroo MS, Cala KM, Russell DW. 5α-Reduced androgens play a key role in murine parturition. Molecular Endocrinology. 1996;10:380–392.
    1. Mahendroo MS, Cala KM, Hess DL, Russell DW. Unexpected virilization in male mice lacking steroid 5α-reductase enzymes. Endocrinology. 2001;142:4652–4662.
    1. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes. 2004;53:931–938.
    1. Morton NM, Densmore V, Wamil M, Ramage L, Nichol K, Bunger L, Seckl JR, Kenyon CJ. A polygenic model of the Metabolic Syndrome with reduced circulating and intra-adipose glucocorticoid action. Diabetes. 2005;54:3371–3378.
    1. Nakano K, Inada Y, Masuzaki H, Tanaka T, Yasue S, Ishii T, Arai N, Ebihara K, Hosada K, Maruyama K, et al. Bezafibrate regulated the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes. American Journal of Physiology. Endocrinology and Metabolism. 2007;292:E1213–E1222.
    1. Opperman UC, Netter KJ, Maser E. Cloning and primary structure of murine 11β-hydroxysteroid microsomal carbonyl reductase. European Journal of Biochemistry. 1995;227:202–208.
    1. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M. Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridisation study. Journal of Clinical Endocrinology and Metabolism. 2002;87:2701–2705.
    1. Phillips DIW, Walker BR, Reynolds RM, Flanagan DEH, Wood PJ, Osmond C, Barker DJ, Whorwood CB. Low birthweight predicts elevated plasma cortisol concentrations in adults from three populations. Journal of Internal Medicine. 2000;35:1301–1306.
    1. Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DEW, Johnson O, Walker BR. Tissue-specific dysregulation of cortisol metabolism in human obesity. Journal of Clinical Endocrinology and Metabolism. 2001;86:1418–1421.
    1. Rask E, Walker BR, Söderberg S, Livingstone DEW, Eliasson M, Johnson O, Andrew R, Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. Journal of Clinical Endocrinology and Metabolism. 2002;87:3330–3336.
    1. Raubenheimer PJ, Nyirenda MJ, Walker BR. A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet. Diabetes. 2006;55:2015–2020.
    1. Sahai M, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whittington PF. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2004;287:G1035–G1043.
    1. Da Silva BA, Bjorbaek C, Uotani S, Flier JS. Functional properties of leptin receptor isoforms containing the Gln-Pro extracellular domain mutation of the fatty rat. Endocrinology. 1998;139:3681–3690.
    1. Surmi BK, Hasty AH. Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidology. 2008;3:545–556.
    1. Tomlinson JW, Finney J, Hughes BA, Hughes S, Stewart PM. Reduced glucocorticoid production rate, decreased 5α-reductase activity and adipose tissue insulin sensitization following weight loss. Diabetes. 2008;57:1536–1543.
    1. Tsilchorozidou T, Honour JW, Conway GS. Altered cortisol metabolism in Polycystic Ovary Syndrome: insulin enhances 5α-reduction but not the elevated adrenal steroid production rates. Journal of Clinical Endocrinology and Metabolism. 2003;88:5907–5913.
    1. Voice MW, Seckl JR, Edwards CRW, Chapman KE. 11beta-Hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism. Biochemical Journal. 1996;317:621–625.
    1. Wake DJ, Rask E, Livingstone DEW, Soderberg S, Olsson T, Walker BR. Local and systemic impact of transcriptional upregulation of 11β-hydroxysteroid dehydrogenase type 1 in human adipose tissues in obesity. Journal of Clinical Endocrinology and Metabolism. 2003;88:3983–3988.
    1. Wake DJ, Stimson RH, Tan GD, Andrew R, Homer NZM, Karpe F, Walker BR. Influence of peroxisome proliferator-activated receptor (PPAR) α and γ agonists on 11β-hydroxysteroid dehydrogenase type 1 in vivo in humans. Journal of Clinical Endocrinology and Metabolism. 2007a;92:1848–1856.
    1. Wake DJ, Strand M, Rask E, Westerbacka J, Livingstone DEW, Soderberg S, Andrew R, Olsson T, Yki-Jarvinen H, Walker BR. The influence of intra-adipose enzymes generating estrogens and androgens on body fat distribution in idiopathic human obesity. Clinical Endocrinology. 2007b;66:440–446.
    1. Walker BR, Andrew R. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Annals of the New York Academy of Sciences. 2006;1083:165–184.
    1. Westerbacka J, Yki-Jarvinen H, Vehkavaara S, Häkkinen A-M, Andrew R, Wake DJ, Seckl JR, Walker BR. Body fat distribution and cortisol metabolism in healthy men: enhanced 5β-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. Journal of Clinical Endocrinology and Metabolism. 2003;88:4924–4931.
    1. Whitaker EM, Shaw MA, Hervey GR. Plasma oestradiol-17beta and testosterone concentrations as possible causes of the infertility of congenitally obese Zucker rats. Journal of Endocrinology. 1983;99:485–490.
    1. Zhao AZ, Shinohara MM, Huang D, Shimizu M, Eldar-Finkelman H, Krebs EG, Beavo JA, Bornfeldt KE. Leptin induces insulin-like signalling that antagonizes cAMP elevation by glucagon in hepatocytes. Journal of Biological Chemistry. 2000;275:11348–11354.
    1. Zumoff B, Strain GW, Miller LK, Rosner W, Senie R, Seres D. Plasma free and nonsex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. Journal of Clinical Endocrinology and Metabolism. 1990;71:929–931.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe